X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Theranostics

期刊標題檢索 THERANOSTICS 最新評論: 7.22 return and 7.24 receive, very fast and highly efficient. (2025-07-24)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Theranostics]您好,您是該頁面的第 424149 位訪客。

期刊簡介
期刊名稱Theranostics Theranostics
LetPub Score
8.4
55 ratings
Rate

Reputation
8.9

Influence
8.0

Speed
9.0

期刊簡稱THERANOSTICS
ISSN1838-7640
h-index69
CiteScore
CiteScoreSJRSNIPCiteScore Rank
23.903.3702.179
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Medicine (miscellaneous)
Q14 / 433
Category: Medicine
Subcategory: Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q11 / 46

自引率 (2023-2024)0.80%自引率趨勢
掲載範囲
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications
官方網站http://www.thno.org/
在線稿件提交http://www.thno.org/ms/submit
開放訪問Yes
出版商Ivyspring International Publisher
主題領域MEDICINE, RESEARCH & EXPERIMENTAL
出版國/地區AUSTRALIA
發行頻率
創刊年2011
每年文章數394每年文章數趨勢
黃金OA百分比99.82%
OA Related Info
APC: Yes( AUD4500; )
APC waiver:No
Other charges: No
Keywords: in vitro diagnostics and prognostics、in vivo molecular imaging、molecular therapeutics、image-guided therapy、biosensors、personalized medicine
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ17/195
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1838-7640%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Theranostics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 1154.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 181.80
    LANCETH-index: 700

    CiteScore: 87.60
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 96.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 114.50
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 113.30
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 103.80
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 129.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 30.80
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY12038877
    Frontiers in Pharmacology6461947
    BIOMATERIALS1500059
    Cancer Medicine976217
    Oncogenesis943595
    MEDICINE683102
    JOURNAL OF ETHNOPHARMACOLOGY679896
    Archives of Medical Science677721
    Oncology Letters583333
    Frontiers in Immunology531439
  •  

    Theranostics Theranostics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/31)
  [Theranostics] 的評論撰寫評論
作者: 王写写


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-07-24 08:43:42 評論於
7.22 return and 7.24 receive, very fast and highly efficient.
(0) 讚! | 王写写

作者: 王写写


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-11 14:34:25 評論於
July 9th minor edits ➕ formatting adjustments
(0) 讚! | 王写写

作者: 王写写


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-22 16:39:34 評論於
The submission was quickly in review after being submitted on 6.17; it disappeared on 6.22 but is still in review.
(0) 讚! | 王写写

作者: 王写写


領域: 医学
審稿時間: 12.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-20 22:38:15 評論於
Is "In review" for internal audit? Or has it already been decided to send it for external audit? It's agonizing to check the status every day.
(0) 讚! | 王写写

作者: 温和的常常


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-06-20 20:21:49 評論於
Please translate the following paragraph into English: 需要
(0) 讚! | 温和的常常

作者: xcxcxcily


領域: 医学
審稿時間: 6.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-20 12:46:04 評論於
Do you need a full film on WB?
(0) 讚! | xcxcxcily

作者: 王写写


領域: 医学
審稿時間: 12.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-18 03:02:18 評論於
I want to ask, what does "in review" mean? Does it mean it hasn't been sent for external review and is still being edited?
(0) 讚! | 王写写

作者: sss1111


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-15 11:33:11 評論於
Do WB raw data require whole membrane?
(0) 讚! | sss1111

作者: 温和的常常


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-05-28 10:50:45 評論於
Sharing the submission experience for reference:

2025.04.27: Submitted;
2025.05.01: Replace disappeared (sent for external review);
2025.05.21: Notified of minor revisions + formatting changes;
2025.05.27: Minor revisions submitted;
2025.05.28: Final acceptance.

The editorial processing and review speed were very fast and efficient, with a previous rejection also being quick. After getting familiar with the submission system once, I found it very convenient, as there was no need for standard paper formatting and raw data submission for initial review like some traditional journals, somewhat similar to Elsevier's "Your paper your way" model. Only after acceptance, the paper needed to be formatted according to the journal's requirements and all original Western blot membranes and assembled photo images needed to be uploaded. Overall, it was a really good experience, in stark contrast to my previous submission to JAR.
(0) 讚! | 温和的常常

作者: 温和的常常


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-28 10:39:55 評論於
Update, Final acceptance on 2025-5-28.
(0) 讚! | 温和的常常

作者: 温和的常常


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-27 14:53:00 評論於
Revised on May 27, currently in review.
(0) 讚! | 温和的常常

作者: 温和的常常


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-25 20:59:59 評論於
Possible statuses after peer review: ①accept as is, ②minor revision, ③major revision, ④de novo resubmission, ⑤rejection, or ⑥rejection with the possibility of transfer to another Ivyspring journal. (From the official website)
(0) 讚! | 温和的常常

作者: 寻


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-05-23 11:24:34 評論於
"In review" means the paper is already under review, mine has already moved from this status to minor revisions.
(0) 讚! | 寻

作者: 温和的常常


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-22 19:08:15 評論於
Submitted on April 27, 2025; replaced on May 1; minor revisions on May 21, currently under modification. One reviewer, over 30 questions, with a positive attitude, suggesting publication after revisions. The main issues are to add some discussions and make some modifications to details in the article. The journal also expressed interest in the article and requested that the minor revisions be returned within one month. After submitting for so many years, this is the first time encountering minor revisions during the initial review.
(0) 讚! | 温和的常常

作者: Zhang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-14 19:22:40 評論於
Have you changed since then?
(0) 讚! | Zhang

作者: 茯苓-


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-01 10:07:19 評論於
Why is my submission showing as active after I submit it, is there something similar?
(0) 讚! | 茯苓-

作者: edc1111


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-04-01 08:51:00 評論於
After submitting on 3.24, it quickly showed "In review". On 3.29, "Replace" disappeared, and recommended reviewers can still edit. The status remains "In review".
(0) 讚! | edc1111

作者: uncia


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-03-29 21:53:32 評論於
After 16 days of the first review, the manuscript was returned for major revisions, with 17 comments from one reviewer. After two months of additional experiments, the manuscript was resubmitted. The second review involved three reviewers, and feedback was received one month later, totaling 34 comments. The manuscript was resubmitted half a month later and accepted the next day, completing a total of four months.
(1) 讚! | uncia

作者: 嚯呀呼呼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-01-31 18:52:07 評論於
Is it important to invite reviewers for this magazine? Will the journal allow the invited reviewers to review the publication?
(0) 讚! | 嚯呀呼呼

作者: 张果


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-31 17:26:05 評論於
Do you need to provide the original data?
(0) 讚! | 张果

作者: Lucy Larkin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 08:41:06 評論於
It will disappear after review.
(0) 讚! | Lucy Larkin

作者: accept all


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 13:20:25 評論於
Will the replacement disappear after the second review is submitted, or will the replacement always be there during the second review? Thank you everyone.
(0) 讚! | accept all

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-22 23:58:51 評論於
After submitting the revised manuscript, the system status is likely to be updated to "Under review", so please pay attention to it.
(0) 讚! | Adelaide Lawson

作者: 寒阴盼盼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 19:09:26 評論於
May I ask if the "Replace" function will still be available in the second review, or will it also disappear after submission? Thank you, everyone.
(0) 讚! | 寒阴盼盼

作者: Lucy Larkin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-17 14:47:43 評論於
The original images of WB, cells or tissues.
(0) 讚! | Lucy Larkin

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/31)

開始撰寫 [Theranostics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*